Use of (S)-BINOL as NMR chiral solvating agent for the enantiodiscrimination of omeprazole and its analogs

Chirality

Volumn 22, Issue 5, 2010, Pages 472-478

  Redondo, Jordi ^a   Capdevila, Anna ^a   Latorre, Isabel ^a  

^a Department of Research and Development   (Spain)

Author keywords

Enantiomeric purity; Enantiorecognition; Esomeprazole; Host guest; Lansoprazole; Pantoprazole; Rabeprazole

Indexed keywords

2,2' DIHYDROXY 1,1' BINAPHTHYL; LANSOPRAZOLE; OMEPRAZOLE; PANTOPRAZOLE; RABEPRAZOLE;

ARTICLE; CHIRALITY; HYDROPHOBICITY; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; SPECTROSCOPY;

DEUTERIUM; MAGNETIC RESONANCE SPECTROSCOPY; NAPHTHOLS; OMEPRAZOLE; SOLVENTS; STEREOISOMERISM;

EID: 77950795439     PISSN: 08990042     EISSN: 1520636X     Source Type: Journal    
DOI: 10.1002/chir.20766     Document Type: Article

References (32)

1. Food and Drug Administration (FDA). Available at: http://www.fda. gov/cder/guidance/stereo.htm, 5/1/1992.
2. Branch S. Subramanian G., editors. International regulation of chiral drugs. Chiral separation techniques. A practical approach. Weinheim: Wiley-VCH; 2001. 319-342.
3. Shindo H, Caldwell J. Development of chiral drugs in Japan: an update on regulatory and industrial opinion. Chirality 1995;7:349-352.
4. Pirkle WH, Hoover DJ. NMR chiral solvating agents. Top Stereochem 1982;13:263-327.
5. Weisman GR. Nuclear magnetic resonance analysis using chiral sol-vating agents. Asymm Synth 1983;1:153-171.
6. Wenzel TJ. Lanthanide chiral solvating agent couples as chiral NMR shift reagents. Trends Org Chem 2000;8:51-64.
7. Yamaguchi S. Nuclear magnetic resonance analysis using chiral derivatives. Asymm Synth 1983;1:125-152.
8. Wenzel TJ, Wilcox JD. Chiral reagents for the determination of enan-tiomeric excess and absolute configuration using NMR spectroscopy. Chirality 2003;15:256-270.
9. Courtieu J, Lesot P, Meddour A, Merlet D, Aroulanda C. Grant DM, Harris R., editors. Chiral liquid crystal NMR: a tool for enantiomeric analysis. Encyclopedia of nuclear magnetic resonance, New York: John Wiley & Sons; 2002. p 497-505.
10. Lindberg P, Brändström A, Wallmark B, Mattsson H, Rikner L, Hoffman KJ. Omeprazole: the first proton pump inhibitor. Med Res Rev 1990;10:1-54. (Pubitemid 20018270)
11. Shi S, Klotz U. Proton pump inhibitors: an update of their clinical use and pharmacokinetics. Eur J Clin Pharmacol 2008;64:935-951.
12. Lindberg P, Keeling D, Fryklund J, Andersson T, Lundborg P, Carlson E. Esomeprazole-enhanced bio-availability, specificity for the proton pump and inhibition of acid secretion. Aliment Pharmacol Ther 2003;17:481-488. (Pubitemid 36384807)
13. Andersson T, Weidolf L. Stereoselective disposition of proton pump inhibitors. Clin Drug Investig 2008;28:263-279. (Pubitemid 351521381)
14. Olbe L, Carlsson E, Lindberg P. A proton-pump inhibitor expedition: the case histories of omeprazole and esomeprazole. Nat Rev Drug Dis-cov 2003;2:132-139. (Pubitemid 37361645)
15. Cirilli R, Ferretti R, Gallinella B, De Santis E, Zanitti L, La Torre F. High-performance liquid chromatography enantioseparation of proton pump inhibitors using the immobilized amylose-based Chiralpak IA chiral stationary phase in normal-phase, polar organic and reversed-phase conditions. J Chromatogr A 2008;1177:105-113. (Pubitemid 350256753)
16. Jenkins AL, Hedgepeth WA. Analysis of chiral pharmaceuticals using HPLC with CD detection. Chirality 2005;17(Suppl):S24-S29. (Pubitemid 40962059)
17. Matlin SA, Tiritan ME, Cass QB, Boyd DR. Enantiomeric resolution of chiral sulfoxides on polysaccharide phases by HPLC. Chirality 1996;8:147-152.
18. Berzas-Nevado JJ, Castaneda-Penalvo G, Rodríguez-Dorado RM. Method development and validation for the separation and determination of omeprazole enantiomers in pharmaceutical preparations by capillary electrophoresis. Anal Chim Acta 2005;533:127-133. (Pubitemid 41373329)
19. Toribio L, Alonso C, Del Nozal MJ, Bernal JL, Jiménez JJ. Enantio-meric separation of chiral sulfoxides by supercritical fluid chromatog-raphy. J Sep Sci 2006;29:1363-1372. (Pubitemid 44122003)
20. Deng J, Chi Y, Fu F, Cui X, Yu K, Zhu J, Jiang Y. Resolution of ome-prazole by inclusion complexation with a chiral host BINOL. Tetrahedron: Asymmetry 2000;11:1729-1732. (Pubitemid 30320894)
21. Coppi L, Berenguer R, Gasanz Y, Medrano J. Process for the preparation of optically active derivatives of 2-(2-pyridylmethylsulfinyl)-benz-imidazole via inclusion complex with 1,1-binaphthalene-2,2-diol, PCT Int. Appl.WO 2006094904 A1. 2006.
22. Toda F, Mori K, Okada J, Node M, Itoh A, Oomine K, Fuji K. New chiral shift reagents, optically active 2,2-dihydroxy-1,1-binaphtyl and 1,6-di(o-chlorophenyl)-1,6-diphenylhexa-2,4-diyne-1,6-diol. Chem Lett 1988;131-134.
23. 1H-NMR spectral non-equivalence of sulph-oxide enantiomers in the presence of 2,2-dihydroxy-1,1-binaphthyl. Sulfur Lett 1989;10:37-40.
24. Ardej-Jakubisiak M, Kawecki R. NMR method for determination of enantiomeric purity of sulfinimines. Tetrahedron: Asymmetry 2008;19: 2645-2647.
25. Liao J, Sun X, Cui X, Yu K, Zhu J, Deng J. Facile optical resolution of tert-butanethiosulfinate by molecular complexation with (R)-BINOL and study of chiral discrimination of the diastereomeric complexes. Chem Eur J 2003;9:2611-2615.
26. 1H-NMR method for the routine spectroscopic determination of enantiomeric purity of active pharmaceutical ingredients fenfluramine, sertraline and paroxetine. Magn Reson Chem 2005;43:910-917.
27. Coppi L, Berenguer R. Method for obtaining derivatives of [[substi-tuted-pyridyl)methyl]thio]benzimidazole, useful as intermediates for omeprazole and related antiulcer agents, PCT Int. Appl. WO 2001079194 A1. 2001.
28. Berenguer R, Campón J, Coppi L. Method for oxidizing a thioether group into a sulfoxide group in benzimidazole derivatives, PCT Int. Appl. WO 2001068594 A1. 2004.
29. Anon. Esomeprazole magnesium trihydrate monograph. European Pharmacopoeia, 6th edition, Available at: http://online.pheur.org/entry.htm, 2009.
30. 13C-NMR study. Magn Reson Chem 2004;42:712-714. (Pubitemid 40012888)
31. Job P. Formation and stability of inorganic complexes in solution. Ann Chim Applicata 1928;9:113-125.
32. Djedaini F, Lin SZ, Perly B, Wouessidjewe D. High-field nuclear magnetic resonance techniques for the investigation of a beta-cyclodextrin: indomethacin inclusion complex. J Pharm Sci 1990;79:643-646. (Pubitemid 20222735)